Department of Pathology, Microbiology and Immunology Core Laboratory
New Automation Instrumentation Reference Ranges
Test Name (units)
Age (>=)
Alpha-1-Antitrypsin (mg/dL)
Acetaminophen Level (mcg/mL)
ALT without P5P (U/L)
Albumin Level (g/dL)
Current Reference Range
Age (<)
Low
High
Age (>=)
0
0
0
1 Month
1 Year
150 Years
150 Years
1 Month
1 Year
150 Years
83
5.0
none
4
4
199
30.0
53
54
40
0
150 Years
3.5
5.0
13.9
150
100
50
40
40
150
100
30
40
40
20
<10
Q24 > 3
Q24 >2
10
none
5
none
Neg
Equivocal 125
Positive
24.6
400
300
375
110
190
400
300
300
110
190
30
0
0
0
1 Year
13 Years
19 Years
0
15 days
1 Year
8 Years
15 Years
19 Years
60 Years
90 Years
0
0
15 days
1 Year
10 Years
13 Years
15 Years
17 Years
19 Years
Q8/Q12 >10
Q8/Q12 >10
35
none
45
299
<125
249
>250
0
150 Years
Male 0
2 Years
2 Years
11 Years
11 Years
19 Years
19 Years
64 Years
64 Years
150 Years
Female 0
2 Years
2 Years
11 Years
11 Years
19 Years
19 Years
64 Years
64 Years
150 Years
Amikacin Level (mcg/mL)
Peak 0
150 yrs
Trough 0
150 yrs
Toxic Trough: Infant/Peds
Toxic Trough: Adult
Ammonia (mcmol/L)
0
150 Years
Amphetamines Immunoassay (ng/mL)
0
150 Years
Amylase, pancreatic (IU/L)
0
150 Years
Amylase, urine (IU/L)
0
150 Years
Antistreptolysin O Quantitative (IU/L)
0
150 Years
Albumin Level CSF (mg/dL)
Alkaline Phosphatase (U/L)
AST activated w/P5P (U/L)
Barbiturates Immunoassay (ng/mL)
Benzodiazepines Immunoassay
(ng/mL)
Beta-Hydroxybutrate (mmol/L)
Bilirubin Direct (mg/dL)
Bilirubin Total (mg/dL)
Buprenorphine (ng/mL)
Calcium Level Total (mg/dL)
0
1 Month
1 Year
1 Month
1 Year
150 Years
20
25
4
65
75
40
0
150 Years
none
none
0
0
0
150 Years
150 Years
150 Years
none
none
0.0
none
0.27
0.3
0
1 day
2 days
5 days
1 Month
1 day
2 days
5 days
1 Month
150 Years
0.2
0.2
0.2
0.2
0.2
6.0
7.0
12.0
10.5
1.2
0
0
7 days
150 Years
7 Days
150 Years
none
7.0
8.5
none
12.0
10.5
0
0
150 Years
150 Years
2.5
100
25
300
Cannabinoids Immunoassay (ng/mL)
Carbon Dioxide Level (mmol/L)
0
0
2 Years
18 Years
150 Years
2 Years
18 Years
150 Years
none
20
18
23
none
24
27
30
Ceruloplasmin (mg/dL)
Chloride Level (mmol/L)
0
0
12 Years
0
0
0
150 Years
12 Years
150 Years
150 Years
150 Years
150 Years
25
99
95
118
50 mEq/L
110 mEq/day
63
111
105
132 mEq/L
250 meEq/L
250 mEq/day
0
150 Years
none
199
0
150 Years
none
none
Calcium - Urine (Spot) (mg/dL)
Calcium - Urine (Timed) (mg/day)
Chloride Level CSF (mmol/L)
Chloride Urine (Spot) (see values)
Chloride Urine (Timed) (see values)
Cholesterol Total (mg/dL)
Cocaine Metabolite Immunoassay
(ng/mL)
Peak 0
Trough 0
Toxic Trough: Infant/Peds
Toxic Trough: Adult
0
0
0
0
0
1 Year
6 Years
19 Years
0
15 days
1 Year
7 Years
12 Years
19 Years
0
Revised Nov 18, 2013
New Reference Range
Age (<)
Low
90
10
5
9
8
0
3.3
2.8
3.8
4.1
4
3.5
3.2
2.9
13.9
90
134
156
141
F 62/M 127
F 54/M 89
F 48/M 59
40
200
30
33
25
24
55
4.5
4.7
4.7
4.8
5.1
5.2
4.6
4.5
24.6
273
518
369
460
F 280/M 517
F 128/M 365
F 95/M 164
150
150 Years
150 Years
20
<10
Q24 > 3
Q24 >2
18
none
5
none
0
0
0
0
32
20
21
18
14
5
none
Q8/Q12 >10
Q8/Q12 >10
72
none
45
299
30
104
331
200
162
67
44
36
35
40
none
none
0
0.3
0.1
0.1
0.1
0.1
0
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.2
none
7.6
none
0.27
0.7
0.3
0.2
0.3
0.4
0.5
6
7
12
10.5
0.7
0.4
0.6
0.7
0.8
1.2
none
10.4
9.0
8.8
8.4
2.5
100
5
50
100
none
5
10
14
17
17
21
23
20
98
98
118
50 mmol/L
110 mmol/day
11.0
10.8
10.5
25
300
40
150
300
none
20
24
24
26
28
29
31
60
113
107
132 mmol/L
250 mmol/L
250 mmol/day
150 Years
150 Years
150 Years
150 Years
< 1 Years
<6 Years
<19 Years
150 Years
<15 days
<1 Year
<7 Years
<12 Years
<19 Years
150 Years
150 Years
0
150 Years
0
150 Years
0
<15 days
15 days
<1 Year
1 Year
<9 Years
9 Years
<13 Years
13 Years
<19 Years
19 Years
150 Years
0
1 day
1 day
2 days
2 days
5 days
5 days
15 days
15 days
<1 Year
1 Years
<9 Years
9 Years
<12 Years
12 Years
<15 Years
15 Years
<19 Years
19 Years
150 Years
0
150 Years
0
<10 days
Comment <10 days Premature range is 6.2 - 11.0
10 days
24 months
2
12
12 Years
150 Years
0
150 Years
0
150 Years
Comment:
Calcium free diet
Low to average diet
Average 800 mg/day
0
150 Years
0
<15 days
15 days
<1 Year
1 Year
<5 Years
5 Years
<15 Years
15 Years F/M
<19 Years F/M
19 Years
<60 Years
60 Years
150 Years
0
150 Years
0
<30 days
1 mo
150 Years
0
150 Years
0
150 Years
0
150 Years
Comment: Range varies greatly with chloride intake
(Consensus) 0
150 Years
0
High
150 Years
150 Years
<1 Year
<13 Years
<19 Years
150 Years
<15 days
<1 Years
<8 Years
<15 Years
<19 Years
<60 Years
<90 Years
150 Years
150 Years
<15 days
<1 Year
<10 Years
<13 Years
<15 Years
<17 Years
<19 Years
150 Years
150 Years
30
0
199
none
none
Department of Pathology, Microbiology and Immunology Core Laboratory
New Automation Instrumentation Reference Ranges
Test Name
Current Reference Range
New Reference Range
C3 Quantitative (mg/dL)
0
150 Years
88
201
C4 Quantitative (mg/dL)
0
150 Years
15
45
Creatine Kinase (U/L)
0
150 Years
30
300
0
2 Years
4 Years
8 Years
11 Years
13 Years
18 Years
0
2 Years
4 Years
8 Years
11 Years
13 Years
18 Years
0
0
2 Years
4 Years
8 Years
11 Years
13 Years
18 Years
150 Years
2 Years
4 Years
8 Years
11 Years
13 Years
18 Years
150 Years
150 Years
150 Years
none
none
none
none
none
none
0.70
none
none
none
none
none
none
0.70
40
1
Creatinine Level (mg/dL)
Creatinine Urine (Spot) (mg/dL)
Creatinine Urine (Timed) (g/day)
C-Reactive Protein HS - Cardiac
(mg/L)
C-Reactive Protein - Inflammatory
(mg/L)
Fructosamine (micromol/L)
GGT (U/L)
Glucose Level (mg/dL)
Glucose Tol Test 50G (mg/dL)
.100 g Glucose 1 Hour (mg/dL)
.Glucose 2 Hour (mg/dL)
.Glucose 3 Hour (mg/dL)
Glucose Baseline (mg/dL)
Glucose CSF (mg/dL)
Glucose Urine (Spot) (mg/dL)
Glucose Urine (Timed) (mg/day)
Haptoglobin (mg/dL)
Cholesterol Level HDL (mg/dL)
Homocysteine (micromol/L)
IgA Quantitative (mg/dL)
IgG Quantitative (mg/dL)
IgG Quantitative CSF (mg/dL)
0
15 days
1 Year
19 Years
0
1 Year
19 Years
0
14 days
<1 Year
<19 Years
150 Years
<1 Year
<19 Years
150 Years
150 Years
0.60
0.70
0.80
0.90
1.00
1.20
1.50
0.50
0.60
0.70
0.80
0.90
1.10
1.50
200
1.6
0
15 days
1 Year
4 Years
7 Years
12 Years
15 Years
17 Years
19 Years
0
150 years
0
<3.0
0
150 Years
none
2.9
0
0
150 Years
150 Years
205
5
285
40
0
7 days
1 Month
1 Year
7 days
30 days
1 Year
150 Years
45
70
70
70
120
110
110
110
0
0
0
0
0
0
0
0
0
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
none
none
none
none
none
45
1
50
16
139
180
155
140
95
75
14.9
300
200
0
0
0
0
1 Month
2 Months
3 Months
5 Months
7 Months
10 Months
1 Year
2 Years
4 Years
6 Years
9 Years
0
1 Month
2 Months
3 Months
5 Months
7 Months
10 Months
1 Year
2 Years
4 Years
6 Years
9 Years
0
150 Years
150 Years
150 Years
1 Month
2 Months
3 Month
5 Months
7 Months
10 Months
1 Year
2 Years
4 Years
6 Years
9 Years
150 Years
1 Month
2 Months
3 Months
5 Months
7 Months
10 Months
1 Year
2 Years
4 Years
6 Years
9 Years
150 Years
150 Years
41
51
5.0
1
3
4
8
11
16
14
14
25
33
45
68
251
206
176
172
217
294
345
424
463
633
608
694
0.5
none
none
15.0
53
47
73
84
90
84
106
159
154
202
236
378
906
601
581
814
904
1069
1213
1135
1236
1280
1572
1618
5.9
<15 days
<1 Year
<4 Years
<7 Years
<12 Years
<15 Years
<17 Years
<19 Years
150 Years
50
51
83
82
7
13
15
Female 29
Male 30
0.42
0.32
0.38
0.44
0.52
0.57
F 0.59/M 0.66
F 0.60/M 0.69
F 0.57/M 0.72
121
160
152
193
30
37
53
168
200
1.05
0.53
0.54
0.64
0.69
0.8
F 0.86/M 1.04
F 0.88/M 1.10
F 1.11/M 1.25
0
0
150 Years
150 Years
40
0.7
200
2.5
18 Years
150 Years
0
2.9
0
14 days
0.3
15 days
<15 Years
0.1
15 Years
<19 Years
0.1
19 Years
150 Years
0
0
150 yrs
205
0
14 days
23
15 days
<1 Year
8
1 Years
< 11 Years
6
11 Years
<19 Years
7
18 Years
150 Years
F 9 /M 12
Newborn, 0
<2 day
40
Comment <2 days: Premature range is 20 - 60 mg/dL
Newborn, 2 day
<1 month
50
Child 1 month
<18 years
60
Adult 18 years
150 Years
70
0
150 Years
none
(CONSENSUS ADA) 0
150 Years
none
0
150 Years
none
0
150 Years
none
0
150 Years
none
0
150 Years
45
0
150 Years
1
0
150 Years
0
0
<15 days
0
15 days
<1 Year
7
1 Year
<12 Years
7
12 Years
<19 Years
7
19 Years
<60 Years
14
60 Years
150 Years
40
(Consensus NCEP) 0
150 Years
F < 50 / M < 40
0
0
3 mos
1 Year
3 Years
6 Years
14 Years
19 Years
60 Years
150 Years
<3mos
1 Year
<3 Years
<6 Years
<14 Years
<19 Years
<60 Years
150 Years
0
<15 days
15 days
<1 Year
1 Years
<4 Years
4 Years
<10 Years
10 Years
<19 Years
19 Years
<80 Years
80 Years
150 Years
No reference range established for > 80 years of age
0
150 Years
6.1
1
1.7
5
285
219
127
16
21
F 36/M 64
60
80
99
99
139
180
155
140
95
75
14.9
499
10
221
163
179
258
273
60
5.0
1
8
0
30
50
50
F 65/M 63
F 69/M 101
15.0
34
91
90
150
220
290
F 421/M 484
F 517/M 645
320
110
320
540
660
F 552/M 540
1400
700
1150
1360
1530
F 1631/M 1822
0.5
5.9
Department of Pathology, Microbiology and Immunology Core Laboratory
New Automation Instrumentation Reference Ranges
Test Name
IgM Quantitative (mg/dL)
Iron Level (mcg/dL)
Lactate Dehydrogenase (IU/L)
Lactate Dehydrogenase CSF (IU/L)
Lactic Acid (mmol/L)
Lactic Acid CSF (mmol/L)
LDL Direct (Chemistry) (mg/dL)
Lipase Level (U/L)
Current Reference Range
0
1
1 Month
2 Months
3 Months
5 Months
7 Months
10 Months
1 Year
2 Years
4 Years
7 Years
9 Years
0
1 Month
1 Year
12 Years
0
1
1 Month
2 Months
3 Months
5 Months
7 Months
10 Months
1 Year
2 Years
4 Years
7 Years
9 Years
150 Years
1 Month
1 Year
12 Years
150 Years
150 Years
0
150 Years
0
150 Years
0
150 Years
0 - 150 yrs
Optimal
Near to Above Optimal
Borderline High
High
Very High
0
150 Years
New Reference Range
0
20
17
24
33
34
41
43
47
43
48
52
60
100
40
50
50
none
19
87
105
101
108
126
149
173
200
196
207
242
263
250
100
120
150
225
0
0.5
0.0
<100
100
130
160
>= 190
10
225
2.2
2.8
60
0
0
150 Years
150 Years
0.6
1.8
1.2
2.4
Magnesium Urine (Spot) (mg/dL)
Magnesium Urine (Timed) (mg/day)
Methadone Immunoassay (ng/mL)
Microalbumin Urine (Spot) (mcg/mL)
Microalbumin Urine (Timed) (mg/day)
Opiate Immunoassay Urine (ng/mL)
0
0
0
0
150 Years
150 Years
150 Years
150 Years
2
70
none
0
20
120
none
14.9 mcg/mL
0
150 Years
none
none
0
0
10
2 Years
150 Years
10
2 Years
150 Years
none
4.5
4.5
2.5
none
9.0
6.7
4.5
0
0
0
10
150 Years
150 Years
10
150 Years
20
400
4.0
3.3
150 mg/dL
1300 mg/day
6.0
4.8
3.5
5.1
Phosphorus Level (mg/dL)
Phosphorus Urine (Spot) (mg/dL)
Phosphorus Urine (Timed) (mg/day)
Potassium Level (mmol/L)
plasma range
Serum range
0
0
0
150 Years
150 Years
150 Years
25
25
18
125 mEq/L
125 mEq/day
45
0
1 Month
3 Months
6 Months
18 Years
40 Years
50 Years
60 Years
0
0
0
0
0
1 Month
3 Months
6 Months
18 Years
40 Years
50 Years
60 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
20
20
15
5
15
20
25
30
none
0
50
2.00
0
170
100
50
40
45
50
55
60
none
<15
100
5.00
15
Salicylate Level (mg/dL)
0
0
1 Month
150 Years
Toxic
1 Month
150 Years
2.0
Sodium Level (mmol/L)
135
135
30.0
>50
145
145
Potassium Urine (Spot) (mmol/L)
Potassium Urine (Timed) (mmol/day)
Prealbumin (mg/dL)
Protein CSF (mg/dL)
Protein Level Body Fluid
Protein Urine (Spot) (mg/dL)
Protein Urine (Timed) (mg/day)
Quinidine Level (mcg/ml)
Rheumatoid Factor Quantitative (IU/ml)
Sodium Urine (Spot) (see values)
Sodium Urine (Timed) (see values)
0
0
150 Years
150 Years
40 mEq/L
100 mEq/day
<15 days
<13 wks
<1 Year
<19 Years
150 Years
10
10
20
F 50/M 40
F 33/M 22
40
70
90
F 190/M 150
F 293/M 240
0
14 Years
19 Years
<14 Years
<19 Years
150 Years
16
20
50
128
168
175
<15 days
<1 Year
<10 Years
<15 Years M/F
<19 Years
150 Years
150 Years
150 Years
150 Years
Optimal
Near to Above Optimal
Borderline High
High
Very High
<19 Years
150 Years
150 Years
<15 days
<1 Year
<19 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 years
150 Years
309
163
192
157
130
125
0
0.5
0.0
<100
100
130
160
>=190
4
8
0.6
2.0
2.0
2.1
1.6
2.0
70
none
0
0
none
1222
452
321
283
250
220
225
2.2
2.8
0
15 days
1 Year
10 Years
15 Years
19 Years
0
0
0
Consensus 0 - 150 yrs
129
159
189
Lithium Level (mmol/L)
Magnesium Level (mg/dL)
Oxycodone Immunoassay Urine
(ng/mL)
0
15 days
13 wks
1 Year
19 Years
220 mEq/L
260 mEq/day
0
19 Years
0
0
15 days
1 Year
19 Years
0
0
0
0
0
0
0
150 yrs
none
0
14 days
5.6
15 days
<1 Year
4.8
1 Year
<5 Years
4.3
5 Years
<13 Years
4.1
13 Years M/F
<16 Years M/F
3.2
16 Years
<19 Years
2.9
19 Years
150 Years
2.3
0
150 Years
20
0
150 Years
400
Newborn, 0
30 days
3.7
Comment <3 days: Premature 0 - 48 hr range is 3.0 - 6.0
Infant 30 days
<1 Year
4.1
Child 1 Year
<12 Years
3.4
Plasma 12 Years
150 Years
3.3
Comment: Serum reference range is higher 3.5 - 5.1 mmol/L
0
150 Years
25
0
150 Years
25
0
<15 days
2
15 days
<1 year
5
1 Year
<5 Years
12
<13 Years
14
5 Years
13 Years
<16 Years
18
16 Years
<19 Years M/F
17
19 Years
<60 Years M/F
16
60 Years
150 Years M/F
14
newborn, 0
1 month
40
Comment < 1 month: Premature range is 15 - 130
General, 1 mo
150 Years
15
0
0
0
0
0
19 Years
0
150 Years
none
150 Years
0
150 Years
0
150 Years
1.5
<19 Years
9
150 Years
0
150 Years
15
Comment: Potentially toxic range is >30
Neonate, 0
<30 days
133
Comment neonates: Premature <48 hour range is 128 - 148 mmol/L
Infant 1 month
<1 Year
139
Child 1 year
<18 Years
138
Adult 18 years
150 Years
136
0
150 Years
40 mmol/L
0
150 Years
40 mmol/day
129
159
189
39
78
1.2
3.9
3.1
2.8
2.6
20
120
none
14.9
29.9
none
none
10.5
8.4
6.8
5.9
6.2
5
4.7
150
1300
5.9
5.3
4.7
4.8
125
125
12
24
23
26
31
35
45
42
120
40
none
14.9
299
5
17
<30
30
146
146
145
144
220 mmol/L
220 mmol/day
Department of Pathology, Microbiology and Immunology Core Laboratory
New Automation Instrumentation Reference Ranges
Test Name
Current Reference Range
New Reference Range
Infant Peak
PEAK Adult
Trough Infant/Peds
Trough Adult
Toxic Trough Peds
Toxic Trough Infant
Toxic Trough Adult
0
0
150 Years
150 Years
2-4 mg/Kg = 5-10 mcg/mL
5-10 mcg/mL
<2 mcg/mL
<0.5 mcg/mL
Q24 > 1 mcg/mL
Q24 > 2 mcg/mL
Q24 > 0.5 mcg/mL
250
6.1
Transferrin (mg/dL)
0
150 Years
212
Tricyclic Antidepressants
Immunoassay (ng/mL)
Triglycerides (mg/dL)
0
150 Years
none
none
0
150 Years
none
none
0
150 Years
none
149
(Consensus) 0
150 Years
0
149
BUN (mg/dL)
0
150 Years
5
25
0
0
0
2 Years
150 Years
150 Years
2 Years
12 Years
300
6
2.0
2.0
1800 mg/dL
17 g/day
7.0
6.5
0
15 days
1 Year
10 Years
19 Years
50 Years
0
0
0
15 days
1 Year
12 Years
19 Years
0
0
0
0
0
0
0
Infant Peak
PEAK Adult
Trough Infant/Peds
Trough Adult
Toxic Trough Peds
Toxic Trough Infant
Toxic Trough Adult
0
0
0
0
<15 days
<1 Year
<10 Years
<19 Years M/F
<50 Years M/F
150 Years M/F
150 Years
150 Years
14 days
<1 Year
<12 Years
<19 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
3
3
9
7
7
8
300
6
2.8
1.6
1.8
2.6
F 2.6/ M 3.5
20
250
23
17
22
21
21
26
1800
20
12.7
6.3
4.9
F 5.9/M 7.6
F 6.0/M 7.2
100
800
Tobramycin Level (mcg/mL)
Iron Binding Capacity Total (mcg/dL)
Protein Level (g/dL)
Urea Urine (Spot) (mg/dL)
Urea Urine (Timed) (g/day)
Uric Acid (mg/dL)
Uric Acid Urine (Spot) (mg/dL)
Uric Acid Urine (Timed) (mg/day)
Tacrolimus
Cyclosporin (ng/mL)
Sirolimus
Carbamazepine Level (mcg/mL)
Digoxin Level (ng/mL)
Gentamicin Level
Lidocaine Level (mcg/mL)
Methotrexate Level (micromol/L)
Phenobarbital Level (mcg/mL)
Phenytoin Level Total (mcg/mL)
Phenytoin Level Free (mcg/mL)
Primidone Level mcg/mL
Procainamide (mcg/mL)
NAPA Level (mcg/mL)
Theophylline Level (mcg/mL)
Valproic Acid Level (mcg/mL)
Valproic Acid Free (mcg/mL)
Vancomycin Level (mcg/mL)
AFP TUMOR (ng/mL)
Beta hCG Quantitative (mIU/mL)
12 Years
0
0
0
0
0
0
0
Infant Peak
PEAK Adult
Trough Infant/Peds
Trough Adult
Toxic Trough Peds
Toxic Trough Infant
Toxic Trough Adult
0
0
0
0
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
0
0
0
0
0
0
0
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 yrs
150 yrs
150 yrs
0
150 Years
0
150 Years
Infant/peds Peak
PEAK Adult
Trough Infant/Peds
Trough Adult
Toxic Trough Infant/Peds
Toxic Trough Adult
Toxic Peak Adult/Infant/peds
0
13 days
14
30 days
1 mo
2 months
2 mo
3 months
3 mo
4 months
4 Months
5 months
5 months
6 months
6 months
1 year
1 year
2 years
2 years
3 years
3 years
150 years
0
150 Years
5-7 mg/kg = >15 mcg/mL
Infant Peak
2-4 mg/Kg = 5-10 mcg/mL
5-7 mg/kg = >15 mcg/mL
PEAK Adult
5-10 mcg/mL
Trough Infant/Peds
<2 mcg/mL
Trough Adult
<0.5 mcg/mL
Q8/Q12 >2 mcg/mL
Toxic Trough Peds
Q24 > 1 mcg/mL
Q8/Q12 >2 mcg/mL
Q8/Q12 >2 mcg/mL
Toxic Trough Infant
Q24 > 2 mcg/mL
Q8/Q12 >2 mcg/mL
Q8/Q12 >2 mcg/mL
Toxic Trough Adult
Q24 > 0.5 mcg/mL
Q8/Q12 >2 mcg/mL
450
0
150 Years
250
450
8.4
0
<15 days
5.3
8.3
15 days
<1 Year
4.4
7.1
1 Year
<6 Years
6.1
7.5
6 Years
<9 Years
6.4
7.7
9 Years
<19 Years
6.5
8.1
19 Years
150 Years
6
8.3
Comment: Serum reference ranges are shown, please note that plasma samples are 0.3 - 0.5 g/dL higher than serum
360
0
<9 wks
104
224
9 wks
<1 Year
107
324
1 Year
<19 Years
220
337
19 Years
<60 Years M/F
174
382
60 Years
150 Years M/F
163
360
2.0
7.0
20
100
250
800
none
none
100
300
none
none
4.0
12.0
0.80
2.00
2-4 mg/Kg = 5-10 mcg/mL 5-7 mg/kg = >15 mcg/mL
5-10 mcg/mL
<2 mcg/mL
<0.5 mcg/mL
Q24 > 1 mcg/mL
Q8/Q12 >2 mcg/mL
Q24 > 2 mcg/mL
Q8/Q12 >2 mcg/mL
Q24 > 0.5 mcg/mL
Q8/Q12 >2 mcg/mL
1.5
5.0
24 hr post infusion
<5.0
48 hrs post infusion
<0.50
72 hrs post infusion
<0.10
Negative LLOQ
<0.04
15.0
40.0
10.0
25.0
0.8
2.0
5.0
15.0
4.0
10.0
10.0
30.0
10.0
20.0
50
6
25-50 mcg/mL
20-40 mcg/mL
5-20 mcg/mL
10-20 mcg/mL
100
20
5000
300
100
40
11
5
0
0
0
0
0
0
>25 mcg/mL
> 20 mcg/mL
> 50 mcg/mL
105,000
60000
10,000
1000
300
200
90
97
41
12
9.9
5
0
Fasting 0
150 Years
150 years
5.0
0.9
100.0
7.1
CA 125 (U/ml)
0
150 Years
none
34.9
CEA (ng/mL)
CK-MB (ng/mL)
0
0
150 Years
150 Years
0.0
none
3.0
5.99
B-Type Natriuretic Peptide (pg/mL)
C-Peptide (ng/mL)
0
0
0
0
0
0
(Neonates) 0
1 month
0
0
Infant/peds Peak
PEAK Adult
Trough Infant/Peds
Trough Adult
Toxic Trough Infant/Peds
Toxic Trough Adult
Toxic Peak Adult/Infant/peds
0
14
1 mo
2 mo
3 mo
4 Months
5 months
6 months
1 year
2 years
3 years
Males 0
Females 0
0
Females 0
Female only - no male range
0
0
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
<1 month
150 Years
150 Years
150 Years
13 days
30 days
2 months
3 months
4 months
5 months
6 months
1 year
2 years
3 years
150 years
70 Years
55 Years
150 Years
Organ specific reference ranges apply
100
300
Organ specific reference ranges apply
4
12
0.8
2
2-4 mg/Kg = 5-10 mcg/mL
5-7 mg/kg = >15 mcg/mL
5-10 mcg/mL
<2 mcg/mL
<0.5 mcg/mL
Q24 > 1 mcg/mL
Q8/Q12 >2 mcg/mL
Q24 > 2 mcg/mL
Q8/Q12 >2 mcg/mL
Q24 > 0.5 mcg/mL
Q8/Q12 >2 mcg/mL
1.5
5.0
24 hr post infusion
<5.0
48 hrs post infusion
<0.50
72 hrs post infusion
<0.10
Negative LLOQ
<0.04
10
40
10
20
0.8
2.0
5.0
12.0
4.0
10.0
5.0
30.0
5
10
10
20
50
100
6
20
25-50 mcg/mL
20-40 mcg/mL
5-20 mcg/mL
10-20 mcg/mL
>25 mcg/mL
> 20 mcg/mL
> 50 mcg/mL
5000
105,000
300
60000
100
10,000
40
1000
11
300
5
200
0
90
0
97
0
41
0
12
0
9.9
0
< 2.0
0
5
10
100
0.7
5.2
150 Years
0
35
150 Years
150 Years
0
0
3
6
Department of Pathology, Microbiology and Immunology Core Laboratory
New Automation Instrumentation Reference Ranges
Test Name
Cortisol (mcg/dL)
Current Reference Range
8AM - 9 AM
11PM
10.4
25% of 8 - 9AM level
New Reference Range
26.4
0 (before 10 AM)
0 (After 5 PM)
150 Years
150 Years
3.7
2.9
19.4
17.3
The Endocrine Society suggests a cut-off of < 1.8 mcg/dL 8 hours after 1 mg-Overnight Dexamethasone
Suppression test or 2 hours after the last dose in the Longer Low-dose Dexamethasone Suppression
Test."
Cystatin C (mg/L)
DHEA-S (mcg/dL)
Estradiol (pg/mL)
0
4 Months
1 Year
18 Years
M/F 0
M/F
M 18 Years
Female
3 Months
<1 Year
17 Years
150 Years
<30 days
Prepubertal
150 Years
premenopausal
postmenopausal
0.50
0.50
0.50
0.50
0
0
80
35
10
2.00
1.50
1.00
1.10
600
98
560
430
190
M/F
Males 18 Years
Female
Prepubertal
150 Years
Follicular
Mid-cycle
Luteal Phase
0
0
0
34
27
0
<30
<56
<160
400
246
<30
Male 20
Female 11
5.9
1.0
2.7
3.9
1.0
25
300
300
24.8
42.5 mIU/mL
15.4
22.0
14.4
160
Postmenopausal
Ferritin (ng/mL)
Folate Level (mg/mL)
FSH (mIU/ml)
0
150 Years
0
Male 18 Years
150 Years
150 years
follicular
peak
Luteal Phase
Postmenopausal
Female 16 Years
Hepatitis A Antibody
Hepatitis A IGM Antibody
Hepatitis B Surface Antibody
Hepatitis B Surface Antigen
Hepatitis B Core Ab Total
Hepatitis C Antibody
Insulin (mcU/mL)
0
0
0
0
0
0
Fasting 0
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
Nonreactive (negative)
Nonreactive (negative)
Nonreactive (negative)
Nonreactive (negative)
Nonreactive (negative)
Nonreactive (negative)
0
<23
0
3 Months
0.50
4 Months
< 1 Year
0.50
1 Year
17 Years
0.50
18 Years
150 Years
0.50
M/F 0
6 days
108
M/F 7 Days
30 Days
32
M/F 1 Month
5 months
3
M/F 6 months
2 Years
0
M/F 3 Years
6 Years
0
M/F 7 Years
9 Years
5
Males 10 Years
14 Years
22
Males 15 Years
19 Years
88
Males 20 Years
29 Years
280
Males 30 Years
49 Years
95
Males 50 Years
59 Years
70
Males 60 Years
150 Years
28
Females 10 Years
14 Years
22
Females 15 Years
29 Years
63
Females 30 Years
49 Years
32
Females 50 Years
59 Years
26
Females 60 Years
150 Years
10
Please include Interpetive Table with all results
DHEA-S Result (mcg/dL)
Tanner Stage
Male
Female
I
7 - 209
7 - 126
II
28 - 260
13-241
III
39-390
32-446
IV&V
81-488
65-371
M/F 15 days
11 months
0
Males - 1 year
10 years
0
Males - 11 years
14 years
0
Males 15 years
18 Years
0
Males - 19 Years
150 Years
11
Females 1 year
8 years
0
Females 9 Years
11 years
0
Females 12 years
13-years
11
Females 14 Years
150 Years
Please see interpretive table
Female Interpretive
Range (pg/mL)
table
Normal Menstruating
Follicular Phase
21 - 251
Mid-Cycle Phase
38 - 649
Luteal Phase
21 - 312
Postmenopausal
0 - 30
Male 0
150 Years
24
Female 0
150 Years
15
WHO range 0
150 Years
5.9
Male 1 month
11 months
0.1
Male 1 Year
9 Years
0
Males 10 Years
18 Years
0.4
Male 19 Years
150 Years
1
Female 1 month
11 months
0.5
Female 1 Year
10 Years
0.4
Female 11 Years
14 Years
0.3
Female 15 Years
150 Years
Please see interpretive table
2.00
1.50
1.00
1.10
607
431
124
33
47
115
332
483
640
530
310
290
255
380
270
200
90
24
13
28
38
44
10
94
172
336
204
24.8
2.4
1.6
5.1
12
11
5.5
7.8
Range
Female- Interpretive ta
(mIU/mL)
Normal Menstruating Females
Follicular Phase
3.0 - 8.0
Mid-Cycle Peak
2.5 - 17.0
Luteal Phase
1.3 - 5.5
Postmenopausal Femal
25 - 135
0
150 Years
Nonreactive (negative)
0
150 Years
Nonreactive (negative)
0
150 Years
Nonreactive (negative)
0
150 Years
Nonreactive (negative)
0
150 Years
Nonreactive (negative)
0
150 Years
Nonreactive (negative)
0
150 Years
0
16
Comment: This test should be measured to establish the pathogenesis of fasting hypoglycemia. The
NACB guidelines suggest that there is no role for routine insulin in most diabetic patients. Diabetes Care
34:e61-e99,2011. Patients receiving insulin therapy may develop anti-insulin antibodies which could
interfere with the assay. This assay shows nearly equimolar cross reactivity (75-150%) with recombinant
human insulin (Actrapid and humulin) and insulin analogs (detemir, aspart, glargine and lispro).
Department of Pathology, Microbiology and Immunology Core Laboratory
New Automation Instrumentation Reference Ranges
Test Name
LH (mIU/mL)
Current Reference Range
Male 18 Years
Female 16 Years
150 years
follicular
peak
luteal Phase
0.3
0.6
7.6
0
10
Postmenopausal
Prostate Specific Ag Total and Free
11 months
9 Years
12 Years
14 Years
150 Years
150 Years
0
0
0
0
0.6
See Interpretive Table
2.9
<0.5
4.3
6.4
12
0
150 Years
10
M/F 0
M/F 3 months
Female
<3 months
prepubertal
follicular
luteal Phase
postmenopausal
150 years
0
0
0
2.5
0
0
0.10
Female
Range
(ng/mL)
Interpretive table
Normal Menstruating Female
Follicular Phase
< 0.3
Luteal Phase
1.2 - 15.9
Postmenopausal
Female
< 0.2
Note: Pediatric Reference Ranges only verified for serum, see CALIPER Study at CaliperDatabase.com
PSA is used to assist in diagnosis and monitoring of prostate cancer. When used as an initial
4.00
Male 18 Years
Prostate Specific Antigen (ng/mL)
M/F 3 months
M/F 1 Year
M/F 10 Years
M/F 13 Years
Males 15 Years
Females 15 Years
Range
Female- Interpretive ta
(mIU/mL)
Normal Menstruating Females
Follicular Phase
1.8 - 11.8
Mid-Cycle Peak
7.0 - 89
Luteal Phase
0.5 - 14
Postmenopausal Femal
5.0 - 62
65
1 Year
8 Years
16
9 Years
16 Years
22
17 Years
18 Years
17
19 Years
150 Years
9
Note: Pediatric Reference Ranges only verified for serum, see CALIPER Study at CaliperDatabase.com
17
M/F 1 month
11 months
0
<1.0
M/F - 1 year
9 years
0
<1.5
M/F -10 years
14 years
0.1
25.0
Male-15 years
Male - 18 years
0.1
<1.0
Male - 18 years
150 years
0
<1.0
Females - 15 Years
150 Years
Please see interpretive table
Parathyroid Hormone Level (pg/mL)
Progesterone (ng/mL)
New Reference Range
15.1
16.6
69
14.9
70
Male 0
150 Years
40
75 Years
63
88
60
77
0.7
0.3
0.8
0.6
0.2
screening test, there is no universally accepted normal range for PSA. The PSA value should be
interpreted in light of factors such as age, race, family history of prostate cancer, digital rectal
examination result, and result of prior prostate biopsy. For more information on calculating
prostate cancer risk based on these factors, see the Prostate Cancer Prevention Trial risk
calculator at http://deb.uthscsa.edu/URORiskCalc/Pages/uroriskcalc.jsp
interpretive table
Interpretive Table in Cerner with all test results
Note: PSA screening is recommended for patients 75 years and younger
In patients with total PSA between 4 - 10 ng/mL and a negative digital rectal exam, and no history of prostate of cancer,
% Free PSA
< 10 ng/mL
10 - 15 ng/mL
15-20 ng/mL
20-26 ng/mL
>26 ng/mL
Probability of Prostate
48.6
37.1
26.9
18.6
1
Cancer (%)
12.5
1
Assumes an overall prevalence of 29% for Prostate Cancer in the tested population
Prolactin (ng/mL)
Male 0
Female
150 Years
premenopausal
Males 0
Female 0
150 Years
150 Years
0
0
0
2.00
0.10
T4 (mcg/dL)
0
150 Years
4.0
Thyroxine, Free (ng/dL)
0
150 Years
0.50
Thyroid Stimulating Hormone
(mcU/mL)
0
150 Years
0.30
postmenopausal
Testosterone Level Total (ng/dL)
Triiodothyronine Level Total (ng/dL)
Troponin-I (ng/mL)
Vitamin B12 Level (pg/mL)
Vitamin D (ng/mL)
<15
<20
<12
11.00
0.60
Male 0
Female 0
150 Years
150 Years
3.46
3
Males 4 days
6 Months
8.6
Males 6 Months
<11 years
0
Males 11 Years
<14 Years
0
Males 14 Years
<16 Years
36
Males 16 Years
<19 Years
147
Males 19 Years
< 50 Years
47
Males 50 Years
150 Years
127
Females 4 days
<9 Years
0
Females 9 Years
< 13 Years
0
Females 13 Years
< 19 Years
10
Females 19 Years
< 50 Years
7.2
Females 50 Years
150 Years
8.6
12.0
1 Year
8 Years
6.16
9 Years
11 Years
5.48
12 Years
16 Years
4.68
17 Years
150 Years
4.6
Note: Pediatric Reference Ranges only verified for serum, see CALIPER Study at CaliperDatabase.com
1.20
5 days
<15 days
1.05
15 days
<30 days
0.68
1 month
<1 year
0.89
1 Year
18 Years
0.89
19 Years
150 Years
0.89
Note: Pediatric Reference Ranges only verified for serum, see CALIPER Study at CaliperDatabase.com
5.00
1 Year
13 Years
0.73
14 Years
18 Years
0.47
19 Years
150 Years
0.35
Note: Pediatric Reference Ranges only verified for serum, see CALIPER Study at CaliperDatabase.com
0
150 Years
80
200
1 Year
11 Years
113
12 Years
14 Years
98
15 Years
16 Years
92
17 Years
18 Years
104
19 Years
150 Years
58
Note: Pediatric Reference Ranges only verified for serum, see CALIPER Study at CaliperDatabase.com
0
150 Years
none
0.04
0
150 Years
0
Comment: "Reference values have not been established for patients < 17 years old."
0
150 Years
180
1000
0
150 Years
213
Deficiency
0
< 10
0 - 150 Years
Deficiency
0
Insufficiency
10
25
Insufficiency
10
Sufficiency
25
80
Sufficiency
25
Toxicity
>80
Toxicity
Note: a pediatric range has not been established for this test
Note: a pediatric range has not been established for this test
19.4
27
299
35.7
444
632
795
981
1020
61
24.2
49
80
36.9
10.32
9.31
8.62
11.72
3.21
2.53
1.7
1.37
1.37
4.09
3.41
3.6
189
176
156
135
160
0.03
816
< 10
25
80
>80
Department of Pathology, Microbiology and Immunology Core Laboratory
New Automation Instrumentation Reference Ranges
Test Name
Albumin Level Body Fluid
Amylase Level Body Fluid
Urea Nitrogen Body Fluid
Calcium Level Body Fluid
Cholesterol Body Fluid
Creatinine Body Fluid
Glucose Body Fluid
Lactate Dehydrogenase Body Fluid
Lipase Level Body Fluid
Potassium Level Body Fluid
Sodium Level Body Fluid
BilirubinTotal Level Body Fluid
Triglyceride Body Fluid
Uric Acid Body Fluid
Carcinoembryonic Antigen Body Fluid
Thyroid Stimulating Hormone Body
Fluid
Beta-HCG Body Fluid
Free T4 Body Fluid
Current Reference Range
New Reference Range
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
150 Years
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
none
0
0
0
150 Years
150 Years
150 Years
none
none
none
none
none
none
0
0
0
150 Years
150 Years
150 Years
none
none
none
none
none
none